 |
 |
 |
OTC drugs |
|
|
OTC Pharmaceuticals in the Czech Republic
Publication Date January 2008
Publisher Datamonitor
Product Type Report
Pages 34
ISBN Number not applicable
Product Code DAT954
|
|
|
Summary
Datamonitor's OTC Pharmaceuticals in the Czech Republic industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by both value and volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer and/or brand
- Also features market breakdown by distribution channel
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
|
Content
- Executive Summary
- Chapter1 Market Overview
- Market Definition
- Highlights
- Chapter2 Market Value
- Chapter3 Market Segmentation I
- Chapter4 Market Segmentation Ii
- Chapter5 Market Share
- Chapter6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
- Chapter7 Leading Companies
- 7.1 Pfizer Inc
- 7.2 Glaxosmithkline Plc
- 7.3 Boiron Sa
- Chapter8 Distribution
- Chapter9 Market Forecasts
- 9.1 Market Value Forecast
- Chapter10 Macroeconomic Indicators
- Chapter11 Appendix
- 11.1 Methodology
- 11.2 Industry Associations
- 11.3 Related Datamonitor Research
- List Of Tables
- Table 1: Czech Republic Otc Pharmaceuticals Market Value: $ Million, 2003-2007
- Table 2: Czech Republic Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Czech Republic Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Czech Republic Otc Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Pfizer Inc
- Table 6: Key Financials: Pfizer Inc
- Table 7: Key Facts: Glaxosmithkline Plc
- Table 8: Key Financials: Glaxosmithkline Plc
- Table 9: Key Facts: Boiron Sa
- Table 10: Key Financials: Boiron Sa
- Table 11: Czech Republic Otc Pharmaceuticals Distribution: % Share, By Value, 2007
- Table 12: Czech Republic Otc Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
- Table 13: Czech Republic Size Of Population (Million) , 2003-2007
- Table 14: Czech Republic Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 15: Czech Republic Inflation, 2003-2007
- Table 16: Czech Republic Exchange Rate, 2003
|
|
|